Fidelity Investments’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268M Sell
6,829,246
-278,389
-4% -$7.71M 0.01% 739
2025
Q4
$109M Sell
7,107,635
-21,561
-0.3% -$430K 0.01% 1135
2025
Q3
$146M Sell
7,129,196
-430,705
-6% -$8.68M 0.01% 1000
2025
Q2
$152M Buy
7,559,901
+950,372
+14% +$18M 0.01% 937
2025
Q1
$130M Buy
6,609,529
+113,658
+2% +$2.45M 0.01% 982
2024
Q4
$146M Buy
6,495,871
+199,692
+3% +$5.18M 0.01% 954
2024
Q3
$161M Buy
6,296,179
+601,611
+11% +$13.9M 0.01% 906
2024
Q2
$133M Sell
5,694,568
-551,725
-9% -$11.6M 0.01% 934
2024
Q1
$110M Buy
6,246,293
+1,085,051
+21% +$16.6M 0.01% 1017
2023
Q4
$71.4M Buy
5,161,242
+1,485,029
+40% +$18.2M 0.01% 1150
2023
Q3
$50.2M Sell
3,676,213
-325,398
-8% -$5.48M ﹤0.01% 1239
2023
Q2
$81.7M Buy
4,001,611
+838,129
+26% +$16.9M 0.01% 1081
2023
Q1
$69.3M Buy
3,163,482
+3,139,646
+13,172% +$63.9M 0.01% 1119
2022
Q4
$390K Buy
+23,836
New +$381K ﹤0.01% 2799
2022
Q2
Sell
-92,540
Closed -$696K 5040
2022
Q1
$696K Sell
92,540
-409,999
-82% -$2.7M ﹤0.01% 2880
2021
Q4
$4.52M Sell
502,539
-75,134
-13% -$985K ﹤0.01% 2392
2021
Q3
$9.43M Sell
577,673
-83,810
-13% -$1.74M ﹤0.01% 2152
2021
Q2
$20.9M Buy
661,483
+99,847
+18% +$3.1M ﹤0.01% 1835
2021
Q1
$19M Sell
561,636
-91,143
-14% -$4.63M ﹤0.01% 1827
2020
Q4
$57.6M Buy
652,779
+33,653
+5% +$2.82M 0.01% 1268
2020
Q3
$50.4M Buy
619,126
+205,280
+50% +$18.5M 0.01% 1188
2020
Q2
$45.7M Buy
413,846
+146,221
+55% +$16.4M 0.01% 1203
2020
Q1
$17.2M Buy
+267,625
New +$17.1M ﹤0.01% 1465

Other funds holding ELVN